Common heart attack drug has no benefits and may raise death risk for women, major study finds

Beta blockers - drugs long prescribed for post-heart attack care - offer no clear benefit for patients whose hearts pump normally after an uncomplicated myocardial infarction, according to a large international trial.

The study also found an increased risk of death and hospitalisation among women who took these drugs.